Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, NK-cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05833893
What this trial is testing

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

Who this might be right for
nk/T-cell LymphomaNewly DiagnosedAdvanced Lymphoma
Chinese PLA General Hospital 10
Early research (Phase 1)Study completedNCT05563545
What this trial is testing

Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Shanghai Simnova Biotechnology Co.,Ltd. 2
Testing effectiveness (Phase 2)UnknownNCT01667302
What this trial is testing

Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT03210662
What this trial is testing

Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Primary Mediastinal (Thymic) Large B-Cell LymphomaRecurrent Aggressive Non-Hodgkin LymphomaRecurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma+8 more
M.D. Anderson Cancer Center 17
Not applicableNot Yet RecruitingNCT07409168
What this trial is testing

Multi-modal Fusion Model and Deep Learning for Predicting Treatment Response in NKTCL

Who this might be right for
Natural Killer/T-cell Lymphoma
Sun Yat-sen University 100
Early research (Phase 1)Study completedNCT02168140
What this trial is testing

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+14 more
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Not applicableUnknownNCT03417414
What this trial is testing

Does CMV Induced Changes in NK Lymphocyte Biology Influence the Effectiveness of Antibody Therapy Used to Treat B Cell Lymphoproliferative Diseases?

Who this might be right for
B Cell Lymphocytic LeukemiaB Cell Non-Hodgkin's Lymphoma
Ottawa Hospital Research Institute 160
Testing effectiveness (Phase 2)UnknownNCT03154918
What this trial is testing

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sichuan University 60
Early research (Phase 1)Study completedNCT03049449
What this trial is testing

T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas

Who this might be right for
Lymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more
National Cancer Institute (NCI) 26
Early research (Phase 1)Ended earlyNCT00354185
What this trial is testing

PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+57 more
National Cancer Institute (NCI) 36
Not applicableLooking for participantsNCT05662540
What this trial is testing

PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma

Who this might be right for
NK/T-cell Lymphoma
Ruijin Hospital 40
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT02276248
What this trial is testing

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Stage I/II Extranodal NK/T-cell Lymphoma
Chinese Academy of Medical Sciences 40
Early research (Phase 1)Study completedNCT00769288
What this trial is testing

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+57 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT06006403
What this trial is testing

Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Acute Myeloid LeukemiaBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Relapse Leukemia+1 more
Chongqing Precision Biotech Co., Ltd 5
Not applicableStudy completedNCT00453206
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Wake Forest University Health Sciences 66
Very early researchUnknownNCT03692767
What this trial is testing

Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Who this might be right for
Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd. 9
Not applicableStudy completedNCT01660568
What this trial is testing

Gemcitabine in NK/T Cell Lymphoma

Who this might be right for
NK/T Cell Lymphoma
Samsung Medical Center 20
Early research (Phase 1)Ended earlyNCT03203369
What this trial is testing

Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Cellectis S.A. 1
Next Page